LLY

775.15

-2.1%↓

JNJ

152.39

+0.45%↑

ABBV

184.42

-0.99%↓

NVO

68.11

+0.95%↑

UNH

306.72

+1.67%↑

LLY

775.15

-2.1%↓

JNJ

152.39

+0.45%↑

ABBV

184.42

-0.99%↓

NVO

68.11

+0.95%↑

UNH

306.72

+1.67%↑

LLY

775.15

-2.1%↓

JNJ

152.39

+0.45%↑

ABBV

184.42

-0.99%↓

NVO

68.11

+0.95%↑

UNH

306.72

+1.67%↑

LLY

775.15

-2.1%↓

JNJ

152.39

+0.45%↑

ABBV

184.42

-0.99%↓

NVO

68.11

+0.95%↑

UNH

306.72

+1.67%↑

LLY

775.15

-2.1%↓

JNJ

152.39

+0.45%↑

ABBV

184.42

-0.99%↓

NVO

68.11

+0.95%↑

UNH

306.72

+1.67%↑

Search

Dr Reddy's Laboratories Ltd-ADR

Deschisă

SectorSănătate

15.03 -1.96

Rezumat

Modificarea prețului

24h

Curent

Minim

14.96

Maxim

15.32

Indicatori cheie

By Trading Economics

Venit

1.8B

16B

Vânzări

1.5B

85B

P/E

Medie Sector

19.628

50.291

EPS

19.11

Randament dividend

0.62

Marjă de profit

18.66

Angajați

27,811

EBITDA

985M

25B

Recomandări

By TipRanks

Recomandări

Cumpărare

Prognoză pe 12 luni

+10.24% upside

Dividende

By Dow Jones

Randament dividend

Medie Sector

0.62%

2.40%

Statistici piață

By TradingEconomics

Capitalizare de piață

10B

13B

Deschiderea anterioară

16.99

Închiderea anterioară

15.03

Scor tehnic

By Trading Central

Încredere

Very Strong Bearish Evidence

Dr Reddy's Laboratories Ltd-ADR Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

9 mai 2025, 18:56 UTC

Câștiguri

Dr Reddy's Laboratories 4Q EPS INR19.11 >RDY

9 mai 2025, 18:56 UTC

Câștiguri

Dr Reddy's Laboratories 4Q Rev INR85.06B >RDY

23 ian. 2025, 17:46 UTC

Câștiguri

Dr. Reddy's 3Q Net Attributable to Equity Holders of Parent Company INR14.13B

23 ian. 2025, 17:42 UTC

Câștiguri

Dr. Reddy's 3Q Rev INR83.59B

5 nov. 2024, 11:01 UTC

Câștiguri

Dr. Reddy's Laboratories 1H Rev INR156.89B Vs. INR136.19B >RDY

5 nov. 2024, 11:00 UTC

Câștiguri

Dr. Reddy's Laboratories 1H Net INR26.47B Vs. Net INR28.825B >RDY

5 nov. 2024, 10:57 UTC

Câștiguri

Dr. Reddy's Laboratories 2Q Net INR12.55B Vs. Net INR14.80B >RDY

5 nov. 2024, 10:57 UTC

Câștiguri

Dr. Reddy's Laboratories 2Q Rev INR80.16B Vs. INR68.80B >RDY

Comparație

Modificare preț

Dr Reddy's Laboratories Ltd-ADR Așteptări

Obiectiv de preț

By TipRanks

10.24% sus

Prognoză pe 12 luni

Medie 16.9 USD  10.24%

Maxim 16.9 USD

Minim 16.9 USD

În baza a 1 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruDr Reddy's Laboratories Ltd-ADR - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

1 ratings

1

Cumpărare

0

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

N/A / 13.84Suport & Rezistență

Termen scurt

Very Strong Bearish Evidence

Termen mediu

Weak Bullish Evidence

Termen lung

Weak Bearish Evidence

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Dr Reddy's Laboratories Ltd-ADR

Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segments. The company's Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations, as well as engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. This segment also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids in accordance with the specific customer requirements. The Others segment engages in developing therapies in the fields of oncology and inflammation; research and development of differentiated formulations; and provides digital healthcare and information technology enabled business support services. The company offers its products for various therapeutic categories primarily include gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology. Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.